Three-dimensional structure-function relationship of vitamin D and vitamin D receptor model

Steroids

Volumn 66, Issue 3-5, 2001, Pages 177-187

  Yamada, Sachiko ^a   Yamamoto, Keiko ^a   Masuno, Hiroyuki ^a   Choi, Mihwa ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Homology modeling; Nuclear receptor; Structure function relationship; Vitamin D

Indexed keywords

AMINO ACID; CALCITRIOL; CELL NUCLEUS RECEPTOR; VITAMIN D; VITAMIN D BINDING PROTEIN; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

BONE; CALCIUM ABSORPTION; CALCIUM MOBILIZATION; CELL DIFFERENTIATION; CONFERENCE PAPER; DRUG CONFORMATION; GENE ACTIVATION; HUMAN; HYDROGEN BOND; INTESTINE ABSORPTION; LIGAND BINDING; MOLECULAR MODEL; MUTATION; NONHUMAN; POINT MUTATION; PROTEIN DOMAIN; RECEPTOR AFFINITY; REVIEW; STRUCTURE ACTIVITY RELATION; THEORY; TRANSACTIVATION;

ANIMALS; HUMANS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; RECEPTORS, CALCITRIOL; STRUCTURE-ACTIVITY RELATIONSHIP; VITAMIN D;

EID: 0035342667     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(00)00145-8     Document Type: Conference Paper

References (44)

1. 3
2. The nuclear receptor superfamily; the second decade
3. 3 analogs with restricted side chain conformation
4. 3 responsible for binding to the receptor
5. 3 and its 20-epimer; Compounds for study of the three-dimensional structure of vitamin D responsible for binding to the receptor
6. Conformation-function relationship of vitamin D; Conformational analysis predicts potential side chain structure
7. Three-dimensional structure-function relationship of vitamin D; side chain location and various activities
8. Three-dimensional modeling of and ligand docking to vitamin D receptor ligand-binding domain
9. Structure-function relationships in the vitamin D endocrine system
10. 3 analogues; A novel class of potent regulators of cell growth and immune responses
11. 3, is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice
12. 3
13. 3 analogues on the proliferation and differentiation of cultured human keratinocytes, calcium metabolism and the differentiation of human HL-60 cells
14. 3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism
15. 3; preferential activity in inducing differentiation of human leukemia cells HL-60 in vitro
16. 3 compounds; separation of calcium and cell differentiation activities
17. 3 for calcium regulating activity
18. 3 on differentiation-inducing activity of human promyelocytic leukemia (HL-60) cells in serum-supplemented or serum-free culture
19. 3
20. 3 26,23-lactone in inducing differentiation of human myeloid leukemia cells
21. Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60
22. 3
23. Induction of monocytic differentiation of HL-60 cells by 1α,25-dihydroxyvitamin D analogs
24. Synthesis and biological activity of 1α-hydroxylated vitamin D analogues with poly-unsaturated side chains
25. The 16-ene-analogs of 1α,25-dihydroxycholecalciferol synthesis and biological activity
26. The 16-ene vitamin D analogs
27. Chemistry and biology of 22,23-yne analogues of calcitiol
28. Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo
29. Nuclear-receptor ligands and ligand-binding domains
30. 3D model of the ligand binding domain of the vitamin D nuclear receptor based on the crystal structure of holo RARγ
31. 3
32. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid
33. Evolution of the nuclear receptor gene superfamily
34. Antagonism in the human mineralocorticoid receptor
35. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid
36. Molecular basis of agonism and antagonism in the oestrogen receptor
37. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains
38. Atomic structure of progesterone complexed with its receptor
39. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
40. 3
41. 3 analogs substituted at the 2β-position and their preventive effects on bone mineral loss in ovariectomized rats
42. 3
43. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand